Luca Boni

14.7k total citations · 3 hit papers
223 papers, 7.7k citations indexed

About

Luca Boni is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Luca Boni has authored 223 papers receiving a total of 7.7k indexed citations (citations by other indexed papers that have themselves been cited), including 115 papers in Oncology, 85 papers in Pulmonary and Respiratory Medicine and 42 papers in Surgery. Recurrent topics in Luca Boni's work include Colorectal Cancer Treatments and Studies (52 papers), Lung Cancer Treatments and Mutations (43 papers) and Lung Cancer Research Studies (28 papers). Luca Boni is often cited by papers focused on Colorectal Cancer Treatments and Studies (52 papers), Lung Cancer Treatments and Mutations (43 papers) and Lung Cancer Research Studies (28 papers). Luca Boni collaborates with scholars based in Italy, United States and United Kingdom. Luca Boni's co-authors include Sara Lonardi, Giuseppe Tonini, Chiara Cremolini, Fotios Loupakis, Alfredo Falcone, Andrea Ardizzoni, Marcello Tiseo, Alberto Zaniboni, Giacomo Allegrini and Silvana Chiara and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Luca Boni

217 papers receiving 7.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study

2015 733 citations Chiara Cremolini, Fotios Loupakis et al. profile →
Initial Therapy with FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer

2014 720 citations Fotios Loupakis, Chiara Cremolini et al. profile →
Primary Tumor Response to Preoperative Chemoradiation With or Without Oxaliplatin in Locally Advanced Rectal Cancer: Pathologic Results of the STAR-01 Randomized Phase III Trial

2011 535 citations C. Aschele, L. Cionini et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Luca Boni

Since Specialization

Citations

This map shows the geographic impact of Luca Boni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luca Boni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luca Boni more than expected).

Fields of papers citing papers by Luca Boni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luca Boni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luca Boni. The network helps show where Luca Boni may publish in the future.

Co-authorship network of co-authors of Luca Boni

This figure shows the co-authorship network connecting the top 25 collaborators of Luca Boni. A scholar is included among the top collaborators of Luca Boni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luca Boni. Luca Boni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prognostic implications of risk definitions from the monarchE and NATALEE trials 2025 ·JNCI Journal of the National Cancer Institute ·Luca Arecco, Eva Blondeaux, Marco Bruzzone, Grazia Arpino, Carmine De Angelis, Michelino De Laurentiis, Roberta Caputo, Alessandra Fabi, Valeria Sanna, Stefania Gori, Fabio Puglisi, Luca Boni, Simone Nardin, (unknown), Marta Perachino, Roberto Borea, Elisa Agostinetto, Evandro de Azambuja, (unknown), Lucia Del Mastro	3
2	Abstract PO4-04-05: HER2 immunohistochemistry (IHC) expression in HER2-positive (HER2-pos) metastatic breast cancer (mBC): clinical and prognostic differences between IHC 2+ and IHC 3+ populations 2024 ·Cancer Research ·(unknown), Eva Blondeaux, Claudia Bighin, (unknown), Stefania Russo, (unknown), (unknown), Andrea Fontana, Enrico Cortesi, (unknown), Ferdinando Riccardi, Valentina Sini, Luca Boni, Alessandra Fabi, Filippo Montemurro, Michelino De Laurentiis, Grazia Arpino, Lucia Del Mastro, Lorenzo Gerratana, Fabio Puglisi	1
3	Epidemiology of malignant brain tumors in Genova, Italy. 1993–2017 2024 ·Scientific Reports ·Guido Fròsina, Claudia Casella, Antonella Puppo, Enza Marani, (unknown), Luca Boni, Vincenzo Fontana	2
4	MA01.03 Neoadjuvant Alectinib in Potentially Resectable Stage III ALK-Positive NSCLC: Interim Analysis of ALNEO-GOIRC-01-2020 Phase II Trial 2024 ·Journal of Thoracic Oncology ·(unknown), Luca Boni, (unknown), (unknown), (unknown), (unknown), (unknown), Alessandra Bearz, (unknown), Francesco Gelsomino, (unknown), (unknown), (unknown), (unknown), (unknown), Fabiana Letizia Cecere, Serena Ricciardi, (unknown), (unknown), (unknown)	1
5	“If you cannot measure it, you cannot improve it”. Outcome measures in Duchenne Muscular Dystrophy: current and future perspectives 2024 ·Acta Neurologica Belgica ·Silvia Benemei, Francesca Gatto, Luca Boni, Marika Pane	2
6	Tip‐microVapour Fast Freezing: A novel easy method for cryopreserving severe oligozoospermic samples 2023 ·Andrology ·Sara Dabizzi, (unknown), Selene Degl’Innocenti, Luca Boni, Linda Vignozzi, Mario Maggi, Elisabetta Baldi, Monica Muratori	0
7	SO-28 FOLFOXIRI plus bevacizumab and atezolizumab as upfront treatment of unresectable mCRC patients: Updated and overall survival results of the phase II randomized AtezoTRIBE study 2023 ·Annals of Oncology ·Carlotta Antoniotti, Daniele Rossini, Filippo Pietrantonio, Lisa Salvatore, Federica Marmorino, Margherita Ambrosini, Sara Lonardi, Maria Bensi, Roberto Moretto, (unknown), (unknown), Alessandro Passardi, Marina Grandis, Veronica Conca, (unknown), (unknown), Aurélie Catteau, Luca Boni, Jérôme Galon, Chiara Cremolini	2
8	Impact of secondary mitral valve chordal cutting on valve geometry in obstructive hypertrophic cardiomyopathy with marked septal hypertrophy 2022 ·European Heart Journal - Cardiovascular Imaging ·(unknown), Paolo Spirito, (unknown), Davide Margonato, Daniele Poggio, Giuseppe Vaccari, (unknown), Massimiliano Grillo, (unknown), Luca Boni, Paolo Ferrazzi	5
9	Study protocol: treatment with caffeine of the very preterm infant in the delivery room: a feasibility study 2020 ·BMJ Open ·Carlo Dani, Alessandra Cecchi, Giulia Remaschi, (unknown), Giancarlo la Marca, Luca Boni, Fabio Mosca	3
10	Endoscopic Full-thickness Resection with the Full-Thickness Resection Device (FTRD) for "difficult to resect" colonic lesions. A single-center experience. 2020 ·PubMed ·(unknown), (unknown), Michele Rossi, Fabio Cianchi, Fabio Staderini, Luca Boni, (unknown), Laura Fortuna, Roberto Manetti	3
11	TREC and KREC in very preterm infants: reference values and effects of maternal and neonatal factors 2019 ·The Journal of Maternal-Fetal & Neonatal Medicine ·Giulia Remaschi, Silvia Ricci, Martina Cortimiglia, (unknown), (unknown), Luca Boni, Chiara Azzari, Carlo Dani	13
12	Clinical outcomes after palbociclib with or without endocrine therapy in postmenopausal women with hormone receptor positive and HER2-negative metastatic breast cancer enrolled in the TREnd trial 2019 ·Breast Cancer Research ·Lorenzo Rossi, Chiara Biagioni, Amelia McCartney, Ilenia Migliaccio, Giuseppe Curigliano, Giuseppina Sanna, Erica Moretti, Alessandro Marco Minisini, Saverio Cinieri, Carlo Tondini, Grazia Arpino, Antônio Bernardo, Angelo Martignetti, Emanuela Risi, Marta Pestrin, Luca Boni, Matteo Benelli, Laura Biganzoli, Angelo Di Leo, Luca Malorni	20
13	Analysis of Prognostic Factors for Resected Synchronous and Metachronous Liver Metastases from Colorectal Cancer 2018 ·Gastroenterology Research and Practice ·Ilenia Bartolini, Maria Novella Ringressi, (unknown), (unknown), Marco Brugia, Enrico Mini, Giacomo Batignani, Paolo Bechi, Luca Boni, Antonio Taddei	15
14	Long-term outcome results of the phase III PROMISE-GIM6 study evaluating the role of LHRH analog (LHRHa) during chemotherapy as a strategy to reduce ovarian failure in early breast cancer patients 2015 ·Annals of Oncology ·Matteo Lambertini, Luca Boni, Andrea Michelotti, Teresa Gamucci, (unknown), Stefania Gori, Monica Giordano, Ornella Garrone, Alessia Levaggi, Francesca Poggio, S. Giraudi, Claudia Bighin, C Vecchio, M.R. Sertoli, (unknown), P. Pronzato, Lucia Del Mastro	26
15	Folfoxiri with or Without Bevacizumab (Bev) As First-Line Treatment of Metastatic Colorectal Cancer (Mcrc): a Propensity Score-Based Analysis 2014 ·Annals of Oncology ·Chiara Cremolini, Fotios Loupakis, Daniele Rossini, Gianluca Masi, Lisa Salvatore, C. Barbara, I. Brunetti, Carlotta Antoniotti, Cristina Granetto, Enrico Cortesi, S. Chiara, S. Vitello, Sara Lonardi, L. Ciuffreda, Giovanni Tomasello, Monica Ronzoni, Angela Buonadonna, (unknown), Luca Boni, Alfredo Falcone	2
16	Risk of Sudden Death and Outcome in Patients With Hypertrophic Cardiomyopathy With Benign Presentation and Without Risk Factors 2014 ·The American Journal of Cardiology ·Paolo Spirito, Camillo Autore, Francesco Formisano, Gabriele Egidy Assenza, Elena Biagini, Tammy S. Haas, Sergio Bongioanni, Christopher Semsarian, Emmanuela Devoto, Beatrice Musumeci, (unknown), Laura Yeates, Maria Rosa Conte, Claudio Rapezzi, Luca Boni, Barry J. Maron	84
17	Primary Tumor Response to Preoperative Chemoradiation With or Without Oxaliplatin in Locally Advanced Rectal Cancer: Pathologic Results of the STAR-01 Randomized Phase III Trial breakdown → 2011 ·Journal of Clinical Oncology ·C. Aschele, L. Cionini, Sara Lonardi, Carmine Pinto, Stefano Cordio, Gerardo Rosati, Salvatore Artale, A. Tagliagambe, (unknown), Paola Rosetti, Andrea Bonetti, Maria Emanuela Negru, Maria Chiara Tronconi, Gabriele Luppi, Giovanni Silvano, Domenico Corsi, Anna Maria Bochicchio, Germana Chiaulon, (unknown), Luca Boni	535
18	Ambamustine in the Second-Line Treatment of Patients With Small-Cell Lung Cancer 2000 ·American Journal of Clinical Oncology ·Andrea Ardizzoni, Giovanna Antonelli, Sante Basso Ricci, G. Frasci, Monica Rinaldi, Luca Boni, Pierre M. Galletti, M.C. Pennucci, Andrea Antonuzzo, Adriano Gravina, Luca Galli, G. Comella, Pierfranco Conté, (unknown), R. Rosso	7
19	Prognostic significance of transesophageal echocardiography and carotid echo Doppler findings in patients with acute cerebral ischemia: Preliminary report of the PRIST study 1996 ·Journal of the American College of Cardiology ·(unknown), (unknown), Luca Boni, Sabino Iliceto, P Rizzon	0
20	Effects of l-carnitine administration on left ventricular remodeling after acute anterior myocardial infarction: the l-Carnitine Ecocardiografia Digitalizzata Infarto Miocardico (CEDIM) trial 1995 ·Journal of the American College of Cardiology ·Sabino Iliceto, Domenico Scrutinio, Paolo Bruzzi, G DʼAmbrosio, Luca Boni, Matteo Di Biase, G Biasco, Paul G. Hugenholtz, P Rizzon	122

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact